Cell response of Escherichia coli to cisplatin-induced stress
Cisplatin is undoubtedly one of the most common and successful anticancer drugs worldwide. Though its DNA‐based mechanism of action is well established, the contribution of the proteome to this process remains unclear. The possible impact of particular Escherichia coli proteins on the cytostatic act...
Saved in:
Published in | Proteomics (Weinheim) Vol. 11; no. 21; pp. 4174 - 4188 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
01.11.2011
WILEY‐VCH Verlag Wiley-VCH Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cisplatin is undoubtedly one of the most common and successful anticancer drugs worldwide. Though its DNA‐based mechanism of action is well established, the contribution of the proteome to this process remains unclear. The possible impact of particular Escherichia coli proteins on the cytostatic activity of cisplatin was the subject of this study. Our main focus was not only the ”bottom‐up” identification of novel cisplatin protein targets through LC/LC‐MS/MS analysis, but also a label‐free quantification of their regulation profile by spectral‐counting. The regulation of two proteins, aconitate hydratase 2 and 60 kDa chaperonin 1, could be linked to a platinated amino acid in the protein sequence, whereas in the cases of 30S ribosomal protein S1 and enolase, it could be shown that cisplatin fragments are coordinated to an essential site for the functionality of the protein. Nucleoside triphosphate pyrophosphohydrolase (MazG) regulates the programmed cell death and was found to be platinated on the protein surface, which probably correlates with the established mode of action. A possible new chapter in the understanding of cisplatin's mechanism of action and its severe side effects is opened, since evidence is provided that platinated proteins are not only involved in cellular stress response but also in energy metabolism through glycolysis and catabolic processes, in gene regulatory mechanisms and protein synthesis. |
---|---|
Bibliography: | ark:/67375/WNG-J5TF0SFN-Q Deutsche Forschungsgemeinschaft (DFG) - No. FOR630 istex:8B6CC903189DE257690E55E62B00D6FC2A800D80 ArticleID:PMIC201100203 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ISSN: | 1615-9853 1615-9861 1615-9861 |
DOI: | 10.1002/pmic.201100203 |